Sunday June 7, 2020

CPL’s Heraty backing Solvotrin Therapeutics

Several well-known investors put more than €1.5m into drug-making firm

17th May, 2020
Anne Heraty of CPL: invested €250,000 in Solvotrin last year. Picture: Feargal Ward

Anne Heraty, the chief executive of CPL Resources, and David Power, a co-founder of Paddy Power, are among several well-known business figures behind a combined €1.5 million-plus investment in Solvotrin Therapeutics, companies records show.

The figure also includes investment in the drug-making firm by Alan Merriman’s Elkstone Capital, the wealth company that has managed investments for Elle MacPherson, the model, and Nicole Junkermann, the Monaco-based businesswoman.

Solvotrin Therapeutics started out as a Trinity...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Car dealership chain says it has sufficient resources available to ‘manage a significant decline in demand’

Barry J Whyte | 8 hours ago

A business that collects glass from private houses and takes it to the recycling centre for a fee has got an unexpected boost from the Covid-19 lockdown

Aaron Rogan | 8 hours ago

The Capital Group’s move comes as the airline announces that its traffic for May 2020 is down by 99.5 per cent on last year

Barry J Whyte | 8 hours ago